← Back to all trials
Not Yet Recruiting
NCT05643664
The Role of Artificial Intelligence in the Treatment of Abdominal Aortic Aneurysms
Conditions: Frequency of Embolic Complications, Frequency of Ischemic Complications
Sex: All
Ages: 45 Years – 75 Years
Phase: NA
Enrollment: 100
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Location: Russian Federation
Summary
"Pilot randomized prospective clinical study of the effectiveness of the use of artificial intelligence in determining "safe" clamping zones in the surgical treatment of abdominal aortic aneurysms."
Eligibility Criteria
Inclusion Criteria:Patients with aneurysmal dilation of the abdominal aorta, who are shown surgery.Patients who have agreed to participate in this studyExclusion Criteria:Chronic heart failure of functional class III -IV according to NYHA classification;Chronic decompensated "pulmonary" heart;Severe hepatic or renal insufficiency (bilirubin >35 mmol/l, glomerular filtration rate <60 ml/min);Polyvalent drug allergy;Malignant oncological diseases in the terminal stage with a predicted life span of up to 6 months;Acute cerebrovascular accident;
Source: ClinicalTrials.gov (NCT05643664). StuddyBuddy aggregates publicly available trial information.